Population
Mouse transverse aortic constriction (TAC) model and cultured primary cardiac fibroblasts
Comparison
Fibroblast-enriched Kdm2a knockdown and… vs Control mice/cells
Design
Preclinical
Key result
Fibroblast-enriched Kdm2a knockdown improved cardiac function, reduced myocardial hypertrophy, and markedly attenuated interstitial and perivascular fibrosis in a mouse model of pressure overload.
Authors
Loading...
Positions Kdm2a as candidate antifibrotic target in HF; leaves open translation from murine models to patients.
Kdm2a acts as an epigenetic driver of fibroblast-mediated cardiac remodeling and represents a potential therapeutic target for pressure overload-induced heart failure.
Wu et al. (2026) studied Pressure overload-induced myocardial fibrosis. Kdm2a knockdown was evaluated on Cardiac remodeling and fibrosis. Fibroblast-enriched Kdm2a knockdown improved cardiac function, reduced myocardial hypertrophy, and markedly attenuated interstitial and perivascular fibrosis in a mouse model of pressure overload.